SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-021430
Filing Date
2021-04-28
Accepted
2021-04-28 17:00:55
Documents
59
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q vktx-10q_20210331.htm   iXBRL 10-Q 2101526
2 EX-31.1 vktx-ex311_8.htm EX-31.1 20482
3 EX-31.2 vktx-ex312_7.htm EX-31.2 20538
4 EX-32.1 vktx-ex321_6.htm EX-32.1 12828
  Complete submission text file 0001564590-21-021430.txt   7788754

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA vktx-20210331.xsd EX-101.SCH 52705
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE vktx-20210331_cal.xml EX-101.CAL 42056
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vktx-20210331_def.xml EX-101.DEF 172686
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE vktx-20210331_lab.xml EX-101.LAB 404941
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vktx-20210331_pre.xml EX-101.PRE 312526
10 EXTRACTED XBRL INSTANCE DOCUMENT vktx-10q_20210331_htm.xml XML 1500176
Mailing Address 12340 EL CAMINO REAL, SUITE 250 SAN DIEGO CA 92130
Business Address 12340 EL CAMINO REAL, SUITE 250 SAN DIEGO CA 92130 858-704-4660
Viking Therapeutics, Inc. (Filer) CIK: 0001607678 (see all company filings)

IRS No.: 461073877 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37355 | Film No.: 21865176
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences